CellSave Arabia Unveils Perinatal Exosome Banking, Expanding Services Beyond Stem Cell Banking

CellSave Arabia, the largest private stem cell facility in the UAE, is excited to introduce perinatal exosome banking as part of its comprehensive suite of longevity-oriented offerings. This strategic move represents a significant leap forward in medical science and underscores CellSave Arabia’s unwavering commitment to delivering cutting-edge solutions that cater to the holistic well-being of families, and yet again introducing new, groundbreaking innovations in the region.

Exosomes, minuscule extracellular vesicles, serve as messengers in cell-to-cell communication by ferrying vital cellular components to neighboring cells. Clinical investigations have illuminated their potential role in regulating immune responses, facilitating wound healing, and governing cell growth and development.

The versatile utility of exosomes across various therapeutic domains has captured considerable attention in recent years. CellSave Arabia extends this groundbreaking service to expectant families, positioning itself at the forefront of innovation and empowering families with an expanded spectrum of healthcare options.

Through perinatal exosome banking, expecting mothers can preserve these invaluable exosomes sourced from perinatal origins during pregnancy. These harvested exosomes hold the promise of potential use in regenerative therapies for the mother and other family members.

Sarah Al-Hajali, CEO of CellSave Arabia, expressed her enthusiasm, stating, “The introduction of perinatal exosome banking is a revolutionary leap that elevates our commitment to personalized and innovative healthcare to unprecedented heights. By broadening our stem cell banking services to encompass exosome banking, we aim to unlock the full potential of regenerative medicine and provide families with an enriched healthcare landscape.”

The process of isolating and extracting exosomes is seamless and non-intrusive. It entails the gentle collection of exosomes from the newborn’s umbilical cord post-delivery, ensuring a safe and painless experience for both mother and child. These exosomes undergo meticulous preservation at CellSave Arabia’s state-of-the-art facility, adhering to the highest industry standards.

Presently, exosome-based therapies are indicated for an array of conditions, including skin rejuvenation, hair loss treatment, osteoarthritis and joint health, vaginal regeneration, and many more. CellSave Arabia’s foray into perinatal exosome banking expands the horizons of regenerative medicine, promising a brighter and healthier future for families.